Vancomycin blocks autophagy and induces interleukin-1β release in macrophages

14Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Systemic inflammatory response syndrome (SIRS) is a serious condition that can cause organ failure as an exaggerated immunoresponse to the infection or other causes. Recently, autophagy was reported as a key process that regulates inflammatory responses in macrophages. Vancomycin is one of the most commonly prescribed antibiotics for sepsis treatment or following surgery. However, there are no studies on how vancomycin affects autophagy or inflammation. Here, we treated macrophage cell lines with vancomycin and lipopolysaccharides and found that vancomycin blocks autophagy and increases inflammatory responses. This finding suggests that vancomycin should be more cautiously administered in order to prevent unwanted SIRS during sepsis.

Cite

CITATION STYLE

APA

Ha, Y. E., Kong, K. H., Cho, M. H., Kim, D. H., Song, Y. S., & Yoon, S. Y. (2015). Vancomycin blocks autophagy and induces interleukin-1β release in macrophages. Journal of Antibiotics, 68(2), 76–80. https://doi.org/10.1038/ja.2014.112

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free